Optinose to Present at the Jefferies Healthcare Conference
02 Junho 2023 - 2:00PM
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on
patients treated by ear, nose and throat (ENT) and allergy
specialists, today announced that members of its management team
will present a company overview and business update at the
Jefferies Healthcare Conference on June 9, 2023 at 10:00 a.m. ET.
To listen to a webcast of the presentation live,
please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30
days following the conclusion of the event.
About OptinoseOptinose is a
specialty pharmaceutical company focused on serving the needs of
patients cared for by ear, nose and throat (ENT) and allergy
specialists. To learn more, please visit www.optinose.com or
follow us on Twitter and LinkedIn.
Optinose Investor ContactJonathan
Neelyjonathan.neely@optinose.com267.521.0531
OptiNose (NASDAQ:OPTN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
OptiNose (NASDAQ:OPTN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024